Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes: authors' reply

A.M.C. Baven-Pronk, M. J. Coenraad, H.R. van Buuren, RA De Man, K.J. van Erpecum, M. M. Lamers, J.P. Drenth, A.P. van den Berg, U. H. Beuers, J. den Ouden, G.H. Koek, C. M. van Nieuwkerk, G. Bouma, J. T. Brouwer, B. van Hoek

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)684-685
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Volume34
Issue number6
DOIs
Publication statusPublished - Sep 2011

Cite this

Baven-Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., De Man, RA., van Erpecum, K. J., Lamers, M. M., Drenth, J. P., van den Berg, A. P., Beuers, U. H., den Ouden, J., Koek, G. H., van Nieuwkerk, C. M., Bouma, G., Brouwer, J. T., & van Hoek, B. (2011). Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes: authors' reply. Alimentary Pharmacology & Therapeutics, 34(6), 684-685. https://doi.org/10.1111/j.1365-2036.2011.04779.x